Logo image of WHATS.BR

WHAT'S COOKING (WHATS.BR) Stock Fundamental Analysis

EBR:WHATS - Euronext Brussels - BE0003573814 - Common Stock - Currency: EUR

113.5  -1.5 (-1.3%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to WHATS. WHATS was compared to 57 industry peers in the Food Products industry. Both the health and profitability get an excellent rating, making WHATS a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on WHATS. These ratings could make WHATS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

WHATS had positive earnings in the past year.
WHATS had a positive operating cash flow in the past year.
WHATS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years WHATS had a positive operating cash flow.
WHATS.BR Yearly Net Income VS EBIT VS OCF VS FCFWHATS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

WHATS has a Return On Assets of 7.95%. This is amongst the best in the industry. WHATS outperforms 85.96% of its industry peers.
With an excellent Return On Equity value of 21.91%, WHATS belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
WHATS has a better Return On Invested Capital (11.71%) than 94.74% of its industry peers.
WHATS had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 6.38%.
The last Return On Invested Capital (11.71%) for WHATS is above the 3 year average (3.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.95%
ROE 21.91%
ROIC 11.71%
ROA(3y)2.77%
ROA(5y)1.93%
ROE(3y)8.11%
ROE(5y)5.68%
ROIC(3y)3.99%
ROIC(5y)4.06%
WHATS.BR Yearly ROA, ROE, ROICWHATS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

WHATS has a Profit Margin (3.70%) which is comparable to the rest of the industry.
WHATS's Profit Margin has improved in the last couple of years.
WHATS has a Operating Margin of 4.24%. This is comparable to the rest of the industry: WHATS outperforms 47.37% of its industry peers.
WHATS's Operating Margin has improved in the last couple of years.
WHATS has a better Gross Margin (45.10%) than 61.40% of its industry peers.
In the last couple of years the Gross Margin of WHATS has grown nicely.
Industry RankSector Rank
OM 4.24%
PM (TTM) 3.7%
GM 45.1%
OM growth 3Y15.41%
OM growth 5YN/A
PM growth 3Y69.32%
PM growth 5YN/A
GM growth 3Y6.51%
GM growth 5YN/A
WHATS.BR Yearly Profit, Operating, Gross MarginsWHATS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

WHATS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for WHATS remains at a similar level compared to 1 year ago.
Compared to 1 year ago, WHATS has an improved debt to assets ratio.
WHATS.BR Yearly Shares OutstandingWHATS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M
WHATS.BR Yearly Total Debt VS Total AssetsWHATS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

WHATS has an Altman-Z score of 3.46. This indicates that WHATS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.46, WHATS belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
WHATS has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as WHATS would need 2.75 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.75, WHATS belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
A Debt/Equity ratio of 0.46 indicates that WHATS is not too dependend on debt financing.
WHATS has a Debt to Equity ratio (0.46) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 2.75
Altman-Z 3.46
ROIC/WACC1.66
WACC7.06%
WHATS.BR Yearly LT Debt VS Equity VS FCFWHATS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

WHATS has a Current Ratio of 1.43. This is a normal value and indicates that WHATS is financially healthy and should not expect problems in meeting its short term obligations.
WHATS has a Current ratio (1.43) which is in line with its industry peers.
A Quick Ratio of 1.31 indicates that WHATS should not have too much problems paying its short term obligations.
The Quick ratio of WHATS (1.31) is better than 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.31
WHATS.BR Yearly Current Assets VS Current LiabilitesWHATS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

WHATS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 299.28%, which is quite impressive.
The Earnings Per Share has been growing by 39.17% on average over the past years. This is a very strong growth
Looking at the last year, WHATS shows a decrease in Revenue. The Revenue has decreased by -0.01% in the last year.
The Revenue for WHATS have been decreasing by -16.65% on average. This is quite bad
EPS 1Y (TTM)299.28%
EPS 3Y39.17%
EPS 5YN/A
EPS Q2Q%291.45%
Revenue 1Y (TTM)-0.01%
Revenue growth 3Y-16.65%
Revenue growth 5YN/A
Sales Q2Q%-3.86%

3.2 Future

Based on estimates for the next years, WHATS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.29% on average per year.
WHATS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.31% yearly.
EPS Next Y1.9%
EPS Next 2Y4.8%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue Next Year3.29%
Revenue Next 2Y3.11%
Revenue Next 3Y-19.83%
Revenue Next 5Y4.31%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WHATS.BR Yearly Revenue VS EstimatesWHATS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
WHATS.BR Yearly EPS VS EstimatesWHATS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.85, the valuation of WHATS can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of WHATS indicates a rather cheap valuation: WHATS is cheaper than 91.23% of the companies listed in the same industry.
WHATS is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.51 indicates a reasonable valuation of WHATS.
WHATS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WHATS is cheaper than 64.91% of the companies in the same industry.
WHATS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.85
Fwd PE 10.51
WHATS.BR Price Earnings VS Forward Price EarningsWHATS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WHATS indicates a rather cheap valuation: WHATS is cheaper than 91.23% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, WHATS is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.95
EV/EBITDA 4.1
WHATS.BR Per share dataWHATS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
WHATS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.61
PEG (5Y)N/A
EPS Next 2Y4.8%
EPS Next 3Y8.29%

3

5. Dividend

5.1 Amount

WHATS has a Yearly Dividend Yield of 2.55%.
WHATS's Dividend Yield is comparable with the industry average which is at 3.19.
WHATS's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
WHATS.BR Yearly Dividends per shareWHATS.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3 4

5.3 Sustainability

WHATS pays out 25.82% of its income as dividend. This is a sustainable payout ratio.
DP25.82%
EPS Next 2Y4.8%
EPS Next 3Y8.29%
WHATS.BR Yearly Income VS Free CF VS DividendWHATS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M 20M 30M
WHATS.BR Dividend Payout.WHATS.BR Dividend Payout, showing the Payout Ratio.WHATS.BR Dividend Payout.PayoutRetained Earnings

WHAT'S COOKING

EBR:WHATS (6/19/2025, 7:00:00 PM)

113.5

-1.5 (-1.3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-28 2025-02-28/amc
Earnings (Next)N/A N/A
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap211.11M
Analysts84
Price Target140.25 (23.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.55%
Yearly Dividend4.28
Dividend Growth(5Y)N/A
DP25.82%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.29%
Valuation
Industry RankSector Rank
PE 6.85
Fwd PE 10.51
P/S 0.25
P/FCF 8.95
P/OCF 3.51
P/B 1.5
P/tB 2.41
EV/EBITDA 4.1
EPS(TTM)16.57
EY14.6%
EPS(NY)10.79
Fwd EY9.51%
FCF(TTM)12.67
FCFY11.17%
OCF(TTM)32.37
OCFY28.52%
SpS447.44
BVpS75.51
TBVpS47.11
PEG (NY)3.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.95%
ROE 21.91%
ROCE 16.95%
ROIC 11.71%
ROICexc 12.79%
ROICexgc 17.7%
OM 4.24%
PM (TTM) 3.7%
GM 45.1%
FCFM 2.83%
ROA(3y)2.77%
ROA(5y)1.93%
ROE(3y)8.11%
ROE(5y)5.68%
ROIC(3y)3.99%
ROIC(5y)4.06%
ROICexc(3y)4.25%
ROICexc(5y)4.31%
ROICexgc(3y)7.02%
ROICexgc(5y)7.6%
ROCE(3y)5.78%
ROCE(5y)5.87%
ROICexcg growth 3Y-14.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-3.52%
ROICexc growth 5YN/A
OM growth 3Y15.41%
OM growth 5YN/A
PM growth 3Y69.32%
PM growth 5YN/A
GM growth 3Y6.51%
GM growth 5YN/A
F-Score8
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 2.75
Debt/EBITDA 1.02
Cap/Depr 132.59%
Cap/Sales 4.4%
Interest Coverage 6.71
Cash Conversion 95.68%
Profit Quality 76.61%
Current Ratio 1.43
Quick Ratio 1.31
Altman-Z 3.46
F-Score8
WACC7.06%
ROIC/WACC1.66
Cap/Depr(3y)102%
Cap/Depr(5y)92.33%
Cap/Sales(3y)6.24%
Cap/Sales(5y)5.07%
Profit Quality(3y)216.29%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)299.28%
EPS 3Y39.17%
EPS 5YN/A
EPS Q2Q%291.45%
EPS Next Y1.9%
EPS Next 2Y4.8%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.01%
Revenue growth 3Y-16.65%
Revenue growth 5YN/A
Sales Q2Q%-3.86%
Revenue Next Year3.29%
Revenue Next 2Y3.11%
Revenue Next 3Y-19.83%
Revenue Next 5Y4.31%
EBIT growth 1Y109.34%
EBIT growth 3Y-3.8%
EBIT growth 5YN/A
EBIT Next Year55.73%
EBIT Next 3Y10.69%
EBIT Next 5YN/A
FCF growth 1Y17.74%
FCF growth 3Y-9.19%
FCF growth 5YN/A
OCF growth 1Y37.56%
OCF growth 3Y5.86%
OCF growth 5YN/A